Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Case Comprehensive Cancer Center
Bristol-Myers Squibb
Thomas Jefferson University
Thomas Jefferson University
Universitätsmedizin Mannheim
M.D. Anderson Cancer Center
Radiation Therapy Oncology Group
Eastern Cooperative Oncology Group
St. Jude Children's Research Hospital
Bristol-Myers Squibb
St. Jude Children's Research Hospital
Radiation Therapy Oncology Group
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Spectrum Pharmaceuticals, Inc
Baylor College of Medicine
Celgene
University of Texas Southwestern Medical Center
Duke University
National Cancer Institute (NCI)
Radiation Therapy Oncology Group
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Baylor College of Medicine
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
University of California, Davis
Stanford University
Ohio State University Comprehensive Cancer Center
Thomas Jefferson University
National Institutes of Health Clinical Center (CC)
Alliance for Clinical Trials in Oncology
Activartis Biotech
Ain Shams University
University of Rochester
University of Miami
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
National Cancer Institute (NCI)
Duke University
Betta Pharmaceuticals Co., Ltd.
Radiation Therapy Oncology Group
National Cancer Institute (NCI)